GSA Capital Partners’s Nutraceutical International Co NUTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,337
Closed -$361K 2170
2016
Q4
$361K Sell
10,337
-3,200
-24% -$101K 0.02% 1214
2016
Q3
$423K Sell
13,537
-17,844
-57% -$460K 0.02% 1153
2016
Q2
$726K Sell
31,381
-9,262
-23% -$220K 0.04% 846
2016
Q1
$990K Buy
40,643
+26,018
+178% +$630K 0.06% 546
2015
Q4
$378K Buy
+14,625
New +$359K 0.02% 1330
2014
Q3
Sell
-24,929
Closed -$595K 2063
2014
Q2
$595K Buy
24,929
+3,780
+18% +$92.8K 0.03% 1027
2014
Q1
$550K Buy
21,149
+3,829
+22% +$99.3K 0.04% 715
2013
Q4
$464K Sell
17,320
-2,500
-13% -$62.1K 0.04% 906
2013
Q3
$471K Sell
19,820
-4,700
-19% -$107K 0.04% 836
2013
Q2
$501K Buy
+24,520
New +$463K 0.06% 545

Other funds holding NUTR

GSA Capital Partners's NUTR Position: Q1 2017 in Review

GSA Capital Partners sold out of Nutraceutical International Co (NUTR) in Q1 2017, closing a stake of 10,337 shares — an estimated $361K sold.

GSA Capital Partners first reported a position in NUTR in Q2 2013 and held it in 10 quarters. The position peaked at $990K in Q1 2016. 85 funds tracked by Wall St. Rank hold NUTR as of Q1 2017.

  • GSA Capital Partners reported no remaining Nutraceutical International Co position as of Q1 2017 after selling out during the quarter.
  • GSA Capital Partners sold 10,337 Nutraceutical International Co shares in Q1 2017, an estimated $361K.
  • GSA Capital Partners first reported a position in Nutraceutical International Co in Q2 2013 and held it in 10 quarters.
  • GSA Capital Partners's Nutraceutical International Co position peaked at $990K in Q1 2016.
  • 85 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q1 2017.

Based on GSA Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.